Gaudium IVF & Women Health IPO Faces Potential Listing at Discount, GMP Hints at Debut Developments

Gaudium IVF & Women Health IPO Listing

Listing Date: Friday, February 27 Listing on: NSE and BSE

The shares of Gaudium IVF & Women Health are set to make their stock market debut on February 27, following the allotment of the company's initial public offering (IPO). The IPO, which opened on February 20 and closed on February 24, was subscribed 7.27 times, with non-institutional investors bidding for ₹347 crore.

GMP Trend: The grey market premium (GMP) for Gaudium IVF & Women Health remains muted, trading at a premium of ₹-4. Based on this trend, the shares are likely to list at ₹75, which is 5% below the IPO price of ₹79.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

IPO Details: The IPO of Gaudium IVF & Women Health witnessed robust investor interest, attracting bids worth ₹840 crore. The public issue was subscribed 7.60 times in the Retail Individual Investors (RII) category and 14.05 times in the Non-Institutional Investors (NII) segment. The Qualified Institutional Buyers (QIBs) portion saw a subscription of 1.62 times.

IPO Details Summary:

• Offer Size: ₹160 crore
• Bid Amount: ₹840 crore
• Retail Subscription: 7.60 times
• Non-Institutional Subscription: 14.05 times
• QIB Subscription: 1.62 times
• IPO Price Band: ₹75 to ₹79 per share
• Fresh Issue: 1.14 crore equity shares worth ₹90 crore
• Offer-for-Sale: 94.93 lakh shares totaling ₹75 crore
• Net Proceeds: ₹165 crore

Company Overview: Gaudium IVF and Women’s Health Limited is a specialized provider of fertility and women’s healthcare services in India, with a primary focus on assisted reproductive technology (ART) and related reproductive treatments. The company has established a strong presence in the IVF treatment market and is poised for growth with the listing of its shares.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO